Katherine Stueland Sells Shares of GeneDx Holdings Corp. $WGS
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. ($WGS), sold 10,501 shares at an average price of $60.76, for a total transaction of $638,092.21. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
GeneDx Holdings Corp. Stock Down 34.6%
Shares of GeneDx Holdings Corp. ($WGS) traded around $56.42 on Thursday, down 34.6% for the day.
GeneDx Holdings Corp. Earnings
Analysts Set New Price Targets
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Get GeneDx Holdings Corp. alerts
New 13F filings, insider trades, and analyst moves on $WGS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.